Hiv And Hepatitis B Virus Co-Infection
Frequency And Presence Of Hepatic Injuries
DOI:
https://doi.org/10.31686/ijier.vol9.iss9.3319Keywords:
Co-infection, HIV infections, Hepatitis B, HepatopathiesAbstract
The clinical importance of HBV-HIV co-infection comes from the fact that both viruses are highly transmissible and share similar routes of transmission. Co-infected individuals are more likely to develop liver cirrhosis and hepatocellular carcinoma. In view of the above, this manuscript is a quantitative, sectional, descriptive study with secondary data obtained from the analysis of medical records of 88 individuals with chronic hepatitis B. Thus, the purpose of this manuscript is to estimate the frequency of HBV-HIV co-infection and to identify the presence of liver damage. The results revealed an HBV-HIV co-infection rate of 9.1% (8//88), with two individuals being infected with the HIV-HBV-HCV virus concurrently. A large percentage of patients are male and heterosexual. There was a relationship between risky sexual behavior (sex without using a condom, multiple sexual partners) and the acquisition of hepatitis B and HIV. Related to the presence of liver lesions, it was observed that only one patient is diagnosed with liver cirrhosis, but there were no cases of hepatocellular carcinoma. Considering the increase in the quality of life and survival of people with HIV, the need to maintain protocols for the investigation of hepatocellular carcinoma is evident, thus seeking early detection and treatment.
Downloads
References
R. C. Alvariz, Hepatite crônica pelo vírus B (HBV). Revista Hospital Pedro Ernesto, v. 5, n. 1, pp. 16-34, jun. 2006.
I. Baudi, S. Lipima. N. Chin’ombe. S. Matapuri-zinyowera. S. Murakami. M. Isogawa. et al. Molecular epidemiology of co-infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe. Journal of Medical Virology, v. 89, n. 2, pp. 257-66. 2016. DOI: https://doi.org/10.1002/jmv.24641
A. Bertoletti. M. K. Maini. C. Ferrari. The host-pathogeninteractionduring HBV infection: immunological controversies. Antiviral Therapy. v. 15 n. 3, pp. 15-24, 2010. DOI: https://doi.org/10.3851/IMP1620
Brasil. Ministério da Saúde (MS). Secretaria de Vigilância em Saúde. Departamento de DST, Aids e Hepatites Virais. Protocolo Clínico e Diretrizes Terapêuticas para hepatite B e Coinfecções. Brasília: MS; 2017.
D. Y. K. But. C. L. Lai. M. F. Yuen. Natural history of hepatitis-related hepatocellular carcinoma. World Journal of Gastroenterology, v. 14, n. 11, pp. 1652-56. 2008. DOI: https://doi.org/10.3748/wjg.14.1652
J. Catalan. V. Tuffrey. D. Ridge. D. Rosenfeld. What influences quality of life in older people living with HIV? AIDS Research and Therapy, v. 14 n. 1, pp. 14-22, 2017. DOI: https://doi.org/10.1186/s12981-017-0148-9
M. L. Chang. Y. F. Liaw. Hepatitis B flares in chronic hepatitis B: Pathogenesis natural course, and management. Journal of Hepatology, v. 61, n. 6, pp. 1407-17, 2014. DOI: https://doi.org/10.1016/j.jhep.2014.08.033
Y. Dong. C. X. Qiu. X. Xia. J. Wang, H. Zhang. X. Zhang. Hepatitis B virus and hepatitis C virus infection amongHIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study. Archives of Virology, v.160, n. 4, pp. 929-36. 2015. DOI: https://doi.org/10.1007/s00705-014-2311-0
G. Fattovich. F. Bortolotti. F. Donato. Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors. Journal Of Hepatology, v. 48, n. 2, pp. 335-52, 2008. DOI: https://doi.org/10.1016/j.jhep.2007.11.011
M. Ganesan. L. Y. Poluektova. K. K. Kharbanda. N. A. Osna. Human immunodeficiency virus and hepatotropic virus esco-morbidities as the inducers of liver injury progression. World Journal of Gastroenterology, v. 25 n. 4, pp. 398-410, 2019. DOI: https://doi.org/10.3748/wjg.v25.i4.398
M. A. Gomes. D. G. Priolli. J. G. Tralhão. M. F. Botelhoa. Carcinoma hepatocelular: epidemiologia, biologia, diagnóstico e terapias. Revista da Associação Médica Brasileira, v. 59, n. 5, pp. 514-24, 2013. DOI: https://doi.org/10.1016/j.ramb.2013.03.005
D. B. Grego. Trinta anos de enfrentamento à epidemia da Aids no Brasil, 1985-2015. Ciência & Saúde Coletiva, v. 21, n. 2, pp. 1553-64. 2016. DOI: https://doi.org/10.1590/1413-81232015215.04402016
Y. C Hsu, T. C. Yip. H. J. Ho. V. W. Wong. Y. T. Huang. H. B. El-Serag. T. Y. Lee. et al. Development of a scoring system to predict the pat cellular carcinoma in Asians on antivirals for chronic hepatitis B. Journal Of Hepatology. v. 69, n. 2, pp. 278-85, 2018. DOI: https://doi.org/10.1016/j.jhep.2018.02.032
G. N. Ioannou. P. Green. E. Lowy. E. J. Mun. K. Berry. Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis. PLOS ONE. v. 13, n. 9, pp. 2-20, 2018. DOI: https://doi.org/10.1371/journal.pone.0204412
M. Mavilia. G. Y. Wu. HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation. Journal of Clinical and Translational Hepatology, v. 6, n. 3, pp. 296-305, 2018. DOI: https://doi.org/10.14218/JCTH.2018.00016
F. Nakagawa. M. May. A. Phillips. Life expectancy living with HIV. Current Opinion In Infectious Diseases, v. 26, n. 1, pp. 17-25.2013. DOI: https://doi.org/10.1097/QCO.0b013e32835ba6b1
G. V. Papatheodoridis. H. L. Chan. B. E. Hansen. H. L. Janssen. P. Lampertico. Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy. Journal Of Hepato-logy. v. 62, n. 4, pp. 956-67. 2015. DOI: https://doi.org/10.1016/j.jhep.2015.01.002
M. K. Parvez. Chronic hepatitis and infection: risks and controls. Intervirology. v. 56, n. 4, pp. 213-6, 2013. DOI: https://doi.org/10.1159/000349888
R. W. Peeling. D. Boeras. F. Mararinucci. P. Easterbrook. The future of viral hepatitis testing: innovations in testing technologies and approaches. BMC Infection Diseases, v. 14, n. 699, 2017. DOI: https://doi.org/10.1186/s12879-017-2775-0
A. Quaglia. Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist. Journal of Hepatocellular Carcinoma. v. 5, n. 1, pp. 99-108, 2018. DOI: https://doi.org/10.2147/JHC.S159808
D. Salmon-Ceron. C. Lewden. P. Morlat. S. Bévilacqua.; E. Jougla. F. Bonnet. et al. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. Journal of Hepatology. v. 42, n. 6, pp. 799-805, 2005. DOI: https://doi.org/10.1016/j.jhep.2005.01.022
K. P. Singh. M. Crane. J. Audsley. S. R. Lewin. HIV-Hepatitis B virus co-infection: epidemiology, pathogenesis and treatment. AIDS. v. 31.n. 15, pp. 2035-52, 2017. DOI: https://doi.org/10.1097/QAD.0000000000001574
M. S. Sulkowski. Viral hepatitis and HIV coinfection. Journal Of Hepatology. v. 48, n. 2, pp. 353-67, 2008. DOI: https://doi.org/10.1016/j.jhep.2007.11.009
M. Vinikoor. E. Sinkala. R. Chilengi. L. B. Mulenga. B. H. Chi. Z. Zyambo. et al. Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia. Clinical Infectious Diseases. v. 64, n. 10, pp.1343-49, 2017. DOI: https://doi.org/10.1093/cid/cix122
Y. Zenebe. W. Mulu. M. Yimer. B. Abera. Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional study. Bmc Infectious Diseases.;v. 14, n. 602, pp. 1-7. 2014. DOI: https://doi.org/10.1186/1471-2334-14-118
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Júnior de Lima, Leandro, Ana Lúcia Lyrio de Oliveira, Valdir Aragão Nascimento, Josiel Elisandro Werle, Priscila G. S. dos Santos, Luciane M. Piasentini, Luciana Aparecida da Cunha Borges, Anderson de Araújo Martins, Michaela de Oliveira Tognini, Michele Scardine Corrêa de Lemos, Ran Shin Tair, João Amadeu Liceti de Britto
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyrights for articles published in IJIER journals are retained by the authors, with first publication rights granted to the journal. The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author for more visit Copyright & License.
How to Cite
Accepted 2021-08-01
Published 2021-09-01
